Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

246.29
Delayed Data
As of Feb 21
 +1.19 / +0.49%
Today’s Change
163.68
Today|||52-Week Range
249.85
+12.49%
Year-to-Date
Better Buy: CRISPR Therapeutics vs. Intellia
Feb 21 / MotleyFool.com - Paid Partner Content
3 Best Biotech Stocks to Buy for the Next Decade
Feb 16 / MotleyFool.com - Paid Partner Content
Better Buy: Vertex Pharmaceuticals vs. Incyte
Feb 19 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close245.10
Today’s open247.30
Day’s range243.27 - 247.50
Volume1,365,436
Average volume (3 months)1,375,170
Market cap$63.9B
Data as of 4:00pm ET, 02/21/2020

Growth & Valuation

Earnings growth (last year)-44.37%
Earnings growth (this year)+43.78%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+35.47%
P/E ratio54.6
Price/Sales13.82
Price/Book10.48

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+1.41+0.71%
ZTSZoetis Inc-1.32-0.92%
TAKTakeda Pharmaceutica...+0.22+1.18%
----
Data as of 6:30pm ET, 02/21/2020

Financials

Next reporting dateApril 23, 2020
EPS forecast (this quarter)$1.78
Annual revenue (last year)$4.1B
Annual profit (last year)$1.2B
Net profit margin28.49%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Boston, Massachusetts

Forecasts